AFIAS COVID-19 Ab Test System is a rapid in vitro diagnostic fluorescence immunoassay test intended for qualitative detection and differentiation of IgG/IgM antibodies to the novel coronavirus SARS-CoV-2 utilizing whole blood, serum or plasma samples.
Detection Rate by Days
AFIAS COVID-19 Ab Test System Components
AFIAS Test Units
AFIAS-1 and AFIAS-6 are automatic immunoassay systems that measure the concentration of a targeted analyte in a sample, using quantitative or semi-quantitative methods for blood, urine, and other samples. Both units use all-in-one cartridges which automates the entire procedure from sample preparation through analysis. The user simply loads the samples.
For some tests, such as TSH, CRP, PCT, and HbA1c, a quantitative test can be performed using a small sample (10uL or 50uL) of whole blood from a finger or heel using an applicable C-tip (capillary tip).
Uses a single channel, it is optimized for small and
mid-sized hospitals (or clinics) testing up to 6 samples per hour.
Automated test process enables to carry out multiple simultaneous tests for six different samples.
The all-in-one cartridge for the AFIAS analysis system provides convenience to the user simply by loading the sample. AFIAS instrument can measure biomarkers automatically and display the result in a short time. The AFIAS cartridge is marked with a product identification barcode, which can be automatically recognized when inserted into the device.
To learn more about our Antibody Test Units, complete the form below and a representative will contact you shortly
Back to top of page